Michael V. Seiden
238 works · 12,891 citations · h-index 56
Top works
- Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
- Alterations of IgM, IgG, and IgA Synthesis and Secretion by Peripheral Blood and Intestinal Mononuclear Cells from Patients with Ulcerative Colitis and Crohn's Disease
- Detection of circulating tumor cells in men with localized prostate cancer.
- Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy
- Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
- Molecular Genetic Analysis of Posttransplant Lymphoproliferative Disorders
- CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
- Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity.
- Synthetic idiotypes: The third hypervariable region of murine anti-dextran antibodies
- Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study
- Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.
- Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer
- Predictors of skeletal complications in patients with metastatic breast carcinoma
- Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian Cancer
- Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples
- Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission
- Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway